Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival

Oncogene volume 19, pages 1657–1664 (2000)Cite this article

Abstract

The immediate early protein tristetraprolin (TTP) is required to prevent inappropriate production of the cytokine TNF-α, and is a member of a zinc finger protein family that is associated with RNA binding. TTP expression is induced by TNF-α, and evidence indicates that TTP can bind and destabilize the TNF-α mRNA. TTP and the closely related TIS11b and TIS11d proteins are evolutionarily conserved, however, and induced transiently in various cell types by numerous diverse stimuli, suggesting that they have additional functions. Supporting this idea, continuous expression of each TTP/TIS11 protein at physiological levels causes apoptotic cell death. By various criteria, this cell death appears analogous to apoptosis induced by certain oncoproteins. It is also dependent upon the zinc fingers, suggesting that it involves action on appropriate cellular targets. TTP but not TIS11b or TIS11d also sensitizes cells to induction of apoptosis by TNF-α. The data suggest that the TTP and TIS11 immediate early proteins have similar but distinct effects on growth or survival pathways, and that TTP might influence TNF-α regulation at multiple levels.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Ashkenazi A and Dixit VM . 1998 Science 281: 1305–1308

  • Barabino SMLX, Hübner W, Jenny A, Minivielle-Sebastia L and Keller W . 1997 Genes Dev 11: 1703–1716

  • Batchelder C, Dunn MA, Choy B, Suh Y, Cassie C, Shim EY, Shin TH, Mello C, Seydoux G and Blackwell TK . 1999 Genes Dev 13: 202–212

  • Beutler B, Han J, Kruys B and Giroir BP . 1992 Tumor Necrosis Factors the Molecules and their Emerging Role in Medicine Beutler B ed Raven Press New York, NY pp 561–574

    Google Scholar 

  • Brown EJ and Schreiber SL . 1996 Cell 86: 517–520

  • Carballo E, Gilkeson GS and Blackshear PJ . 1997 J Clin Invest 100: 986–995

  • Carballo E, Lai WS and Blackshear PJ . 1998 Science 281: 1001–1005

  • Chandar N, Billig B, McMaster J and Novak J . 1992 Br J Cancer 65: 208–214

  • Chen C-YA and Shyu A-B . 1995 Trends Biochem Sci 20: 465–470

  • Corps AN and Brown KD . 1995 FEBS Lett 368: 160–164

  • DuBois RN, McLane MW, Ryder K, Lau LF and Nathans D . 1990 J Biol Chem 265: 19185–19191

  • Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC . 1992 Cell 69: 119–128

  • Gomperts M, Corps AN, Pascall JC and Brown KD . 1992 FEBS Lett 306: 1–4

  • Gross A, McDonnell JM and Korsmeyer SJ . 1999 Genes Dev 13: 1899–1911

  • Grumont RJ, Rourke IJ and Gerondakis S . 1999 Genes Dev 13: 400–411

  • Guedes S and Priess J . 1997 Development 124: 731–739

  • Hafezi F, Steinbach JP, Marti A, Munz K, Wang Z-Q, Wagner EF, Aguzzi A and Reme CE . 1997 Nat Med 3: 346–349

  • Han J, Wallen HD, Nunez G and White E . 1998 Mol Cell Biol 18: 6052–6062

  • Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD and Haber DA . 1999 Cell 97: 575–586

  • Hsieh J-KX, Fredersdorf S, Kozarides T, Martin K and Lu X . 1997 Genes Dev 11: 1840–1852

  • Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JCF, Trent JM, Staudt LM, Hudson Jr J, Boguski MS, Lashkari D, Shalon D, Botstein D and Brown PO . 1999 Science 283: 83–87

  • Janicke RU, Lee FH and Porter AG . 1994 Mol Cell Biol 14: 5661–5670

  • Juin P, Hueber AO, Littlewood T and Evan G . 1999 Genes Dev 13: 1367–1381

  • Kanoh J, Sugimoto A and Yamamoto M . 1995 Mol Biol Cell 6: 1185–1195

  • Klefstrom J, Vastrik I, Saksela E, Valle J, Eilers M and Alitalo K . 1994 EMBO J 13: 5442–5450

  • Kowalik TF, DeGregori J, Schwarz JK and Nevins JR . 1995 J Virol 69: 2491–2500

  • Lai WS, Carballo E, Strum JR, Kennington EA, Phillips RS and Blackshear PJ . 1999 Mol Cell Biol 19: 4311–4323

  • Lai WS, Stumpo DJ and Blackshear PJ . 1990 J Biol Chem 265: 16556–16563

  • Ma Q and Herschman HR . 1995 Oncogene 10: 487–494

  • Meikrantz W and Schlegel R . 1996 J Biol Chem 271: 10205–10209

  • Mello CC, Schubert C, Draper B, Zhang W, Lobel R and Priess JR . 1996 Nature 382: 710–712

  • Mesner PW, Epting CL, Hegarty JL and Green SH . 1995 J Neurosci 15: 7357–7366

  • Murray MV, Turnage MA, Williamson KJ, Steinhauer WR and Searles LL . 1997 Mol Cell Biol 17: 2291–2300

  • Nevins JR . 1998 Cell Growth Differ 9: 585–593

  • Phillips AC, Bates S, Ryan KM, Helin K and Vousden KH . 1997 Genes Dev 11: 1853–1863

  • Phillips AC, Ernst MK, Bates S, Rice NR and Vousden KH . 1999 Mol Cell 4: 771–781

  • Ross J . 1995 Microbiol Rev 59: 423–450

  • Rudner DZ, Breger KS and Rio DC . 1998 Genes Dev 12: 1010–1021

  • Shaw G and Kamen R . 1986 Cell 46: 659–667

  • Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bisonnette RP and Green D . 1992 Science 257: 212–214

  • Srinivasan A, Li F, Wong A, Kodandapani L, Smidt Jr R, Krebs JF, Fritz LC, Wu JC and Tomaselli KJ . 1998 J Biol Chem 273: 4523–4529

  • Tabara H, Hill RJ, Mello CC, Priess JR and Kohara Y . 1999 Development 126: 1–11

  • Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF and Blackshear PJ . 1996a Immunity 4: 445–454

  • Taylor GA, Thompson MJ, Lai WS and Blackshear PJ . 1996b Mol Endocrinol 10: 140–146

  • Taylor GA, Thompson MJ, Lai WS and Blackshear PL . 1995 J Biol Chem 270: 13341–13347

  • Thompson MJ, Lai WS, Taylor GA and Blackshear PJ . 1996 Gene 174: 225–233

  • Tronchere H, Wang J and Fu X-D . 1997 Nature 388: 397–400

  • Turner D and Weintraub H . 1994 Genes Dev 8: 1434–1447

  • Varnum BC, Lim RW, Sukhatme VP and Herschman HR . 1989 Oncogene 4: 119–120

  • Varnum BC, Ma Q, Chi T, Fletcher B and Herschman HR . 1991 Mol Cell Biol 11: 1754–1758

  • Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin Jr AS . 1998 Science 281: 1680–1683

  • Warbrick E and Glover D . 1994 Gene 151: 243–246

  • Worthington MT, Amann BT, Nathans D and Berg JM . 1996 Proc Natl Acad Sci USA 93: 13754–13759

  • Wu MX, Ao Z, Prasad KV, Wu R and Schlossman SF . 1998 Science 281: 998–1001

  • Zhan Y, Cleveland JL and Stevens JL . 1997 Mol Cell Biol 17: 6755–6764

  • Zong WX, Edelstein LC, Chen C, Bash J and Gelinas C . 1999 Genes Dev 13: 382–387

Download references

Acknowledgements

We thank Mark Worthington for the TTP (Nup475) cDNA, Harvey Herschman for TIS11b and TIS11d cDNAs, and Vishva Dixit for the CrmA expression construct. For helpful discussions and reagents we are grateful to Junying Yuan and Karl Munger, whom we also thank for critically reading this manuscript along with Yang Shi and Blackwell lab members. This work was supported by a fellowship from the Arthritis Foundation to BA Johnson, and by grants from the US Army Breast Cancer Program (17-94-J-4063) and the NIH (PO1 HD17461).

Author information

Authors and Affiliations

  1. Center for Blood Research and Department of Pathology, Harvard Medical School, 200 Longwood Avenue, Boston, 02115, Massachusetts, MA, USA

    Barbra A Johnson, Mayya Geha & T Keith Blackwell

Authors
  1. Barbra A Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mayya Geha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Keith Blackwell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johnson, B., Geha, M. & Blackwell, T. Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival. Oncogene 19, 1657–1664 (2000). https://doi.org/10.1038/sj.onc.1203474

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203474

Keywords

Search

Advanced search

Quick links